Bumrungrad Hospital Public Company Limited (SET: BH) has announced its 3Q22 consolidated financial statement through the Stock Exchange of Thailand as follows;
| Quarter | 3Q22 | 3Q21 |
| Net Profit (Loss) Million Baht |
1,501 | 296 |
| Earning Per Share (Baht) | 1.89 | 0.37 |
| % Change | 407.2 | |
| 6 Months | 2022 | 2021 |
| Net Profit (Loss) Million Baht |
3,392 | 604 |
| Earning Per Share (Baht) | 4.27 | 0.76 |
| % Change | 462 | |
In 3Q22, BH recorded a net profit of THB1,501 million, an increase of 407.2% from a net profit of THB296 million in 3Q21, with net profit margin at 26.2%, compared to 9.9% a year earlier..
Total revenues were at THB5,740 million, a 92.1% increase from THB2,989 million in 3Q21. This was mostly due to an increase in revenues from non-Thai patients and Thai patients by 213.2% and 10.1%, respectively. As a result, the revenue contribution from Thai patients was 32.6%, whereas revenue from non-Thai patients was 67.4% for 3Q22 compared with 57.9% and 42.1%, respectively, for 3Q21.
For the 9-month ended September period, revenues from hospital operations were at THB14,678 million, a 72.2% increase year-over-year from THB8,522 million in 9M21. This was mostly due to an increase in revenues from non-Thai patients and Thai patients by 139.5% and 17.5%, respectively. As a result, the revenue contribution from Thai patients was 37.6%, whereas revenue from non-Thai patients was 62.4% for 9M22 compared with 55.1% and 44.9%, respectively, for 9M21.
